These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3547840)

  • 1. Positive B cell crossmatches in highly sensitized patients--influence of antibody specificity on renal transplant outcome.
    Lazda VA; Pollak R; Mozes MF; Jonasson O
    Transplant Proc; 1987 Feb; 19(1 Pt 1):782-4. PubMed ID: 3547840
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
    Gaber AO; Thistlethwaite JR; Haag BW; Stuart J; Mayes J; Fellner S; Stuart FP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
    Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS
    Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of donor specific transfusion renal transplants across B cell positive crossmatches.
    Balakrishnan K; Munda R; First MR; Alexander JW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1836. PubMed ID: 2652597
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
    Opelz G; Döhler B; Süsal C
    Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of "remote positive" crossmatches and positive B-cell crossmatches in renal transplantation.
    Opelz G
    Transplant Proc; 1990 Aug; 22(4):1878-80. PubMed ID: 2389469
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
    Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT
    Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of kidney transplantation in highly sensitized patients in Scandiatransplant.
    Lamm LU; Madsen M; Fjeldborg D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):729-30. PubMed ID: 3274855
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation.
    Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):247-50. PubMed ID: 8438288
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive B cell crossmatches: specificity of antibody and graft outcome.
    Phelan DL; Rodey GE; Flye MW; Hanto DW; Anderson CB; Mohanakumar T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):687-8. PubMed ID: 2650222
    [No Abstract]   [Full Text] [Related]  

  • 11. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
    Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
    Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recipient sensitization against donor cells in pre- and/or posttransplantation sera is inversely correlated with graft survival.
    Sumitran S; Forsberg I; Lindholm A; Lundgren G; Möller E
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1566-7. PubMed ID: 3274384
    [No Abstract]   [Full Text] [Related]  

  • 14. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
    LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
    Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of transplantation with remote-positive proximate-negative T cell antiglobulin crossmatches.
    Hodge E; Novick A; Lewis R; Steinmuller D; Streem S; Cunningham R; Braun W; Zachary A; Protiva D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):789-91. PubMed ID: 3274874
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal allograft survival in highly sensitized patients treated with cyclosporine.
    Doran M; Coppage M; Ruth J; Fish J; Winsett O; Vaidya S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1988. PubMed ID: 3274458
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation of highly sensitized patients based on crossmatches using DTT-treated sera.
    Alarif L; Snyder T; Light JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):742-4. PubMed ID: 2650251
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma exchange and immunosuppressive therapy before renal transplantation in highly sensitized patients.
    Fauchald P; Leivestad T; Bratlie A; Jakobsen A; Flatmark A
    Transplant Proc; 1987 Feb; 19(1 Pt 1):727-8. PubMed ID: 3274854
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical relevance of pretransplant flow cytometric crossmatches with T and B lymphocytes in kidney transplantation.
    Berteli AJ; Daniel V; Pomer S; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1895-6. PubMed ID: 2389477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.